|Advances in the treatment of malignant gliomas|
M Khasraw, AB Lassman
Current oncology reports 12 (1), 26-33, 2010
|Antiangiogenic therapy for high‐grade glioma|
M Khasraw, MS Ameratunga, R Grant, H Wheeler, N Pavlakis
Cochrane Database of Systematic Reviews, 2014
|Epirubicin: is it like doxorubicin in breast cancer? A clinical review|
M Khasraw, R Bell, C Dang
The Breast 21 (2), 142-149, 2012
|Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma|
A Omuro, TA Chan, LE Abrey, M Khasraw, AS Reiner, TJ Kaley, ...
Neuro-oncology 15 (2), 242-250, 2013
|Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies|
ST Garber, Y Hashimoto, SP Weathers, J Xiu, Z Gatalica, RGW Verhaak, ...
Neuro-oncology 18 (10), 1357-1366, 2016
|EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model|
T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ...
Theranostics 5 (12), 1456, 2015
|Neurological complications of systemic cancer|
M Khasraw, JB Posner
The Lancet Neurology 9 (12), 1214-1227, 2010
|Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience|
M Khasraw, A Holodny, SA Goldlust, LM DeAngelis
Annals of oncology 23 (2), 458-463, 2012
|Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance|
DLH Chan, N Pavlakis, GP Schembri, EJ Bernard, E Hsiao, A Hayes, ...
Theranostics 7 (5), 1149, 2017
|Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry|
S Gupta, T Tran, W Luo, D Phung, RL Kennedy, A Broad, D Campbell, ...
BMJ open 4 (3), 2014
|Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer|
M Khasraw, N Pavlakis, S McCowatt, C Underhill, S Begbie, P de Souza, ...
Annals of oncology 21 (6), 1302-1307, 2010
|Adaptive global innovative learning environment for glioblastoma: GBM AGILE|
BM Alexander, S Ba, MS Berger, DA Berry, WK Cavenee, SM Chang, ...
Clinical Cancer Research 24 (4), 737-743, 2018
|The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?|
M Khasraw, E Brogi, AD Seidman
Current oncology reports 13 (1), 17-25, 2011
|Using lithium as a neuroprotective agent in patients with cancer|
M Khasraw, D Ashley, G Wheeler, M Berk
BMC medicine 10 (1), 131, 2012
|Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?|
M Khasraw, D Bell, H Wheeler
Journal of Clinical Neuroscience 16 (6), 854-855, 2009
|Small bowel video capsule endoscopy: an overview|
BF Mustafa, M Samaan, L Langmead, M Khasraw
Expert review of gastroenterology & hepatology 7 (4), 323-329, 2013
|Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian Gastro-Intestinal …|
E Segelov, S Thavaneswaran, PM Waring, J Desai, KP Robledo, ...
Journal of Clinical Oncology 34 (19), 2258-2264, 2016
|Bevacizumab for the treatment of high-grade glioma: an update after phase III trials|
M Khasraw, M Ameratunga, C Grommes
Expert opinion on biological therapy 14 (5), 729-740, 2014
|Emerging pharmacotherapy for cancer patients with cognitive dysfunction|
J Davis, FM Ahlberg, M Berk, DM Ashley, M Khasraw
BMC neurology 13 (1), 153, 2013
|Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer|
SM Domchek, K Jhaveri, S Patil, JE Stopfer, C Hudis, J Powers, Z Stadler, ...
Cancer 119 (7), 1344-1348, 2013